Page last updated: 2024-08-24

3-iodobenzylguanidine and Central Nervous System Disease

3-iodobenzylguanidine has been researched along with Central Nervous System Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Iwanaga, K; Satoh, A; Satoh, H; Serita, T; Seto, M; Takashima, H; Tomita, I; Tsujihata, M	1

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Central Nervous System Disease

Article	Year
Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:3 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Central Nervous System Diseases; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Sympathetic Nervous System	1999

Article

Year

Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:3

Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Central Nervous System Diseases; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Sympathetic Nervous System

1999